Why the study?
Does PCI reduce cardiovascular death, myocardial infarction, or MACE compared to optimal medical therapy in patients with a single remaining coronary CTO?
Does PCI reduce cardiovascular death, myocardial infarction, or MACE compared to optimal medical therapy in patients with a single remaining coronary CTO?
Answers are grounded in this paper and cite their sources.
In patients with a single coronary CTO, PCI is safe and reduces MACE (driven by less ischaemia-driven revascularization) compared to optimal medical therapy at 3 years, though it does not reduce cardiovascular death or myocardial infarction.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Werner et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: